May 23, 2018
Gilead Sciences to Present at the Jefferies 2018 Healthcare Conference on Wednesday, June 6
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 23, 2018--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F.
Milligan, PhD, Gilead’s President and Chief Executive Officer; Robin L.
Washington, Gilead’s Executive Vice President and Chief Financial
Officer; John McHutchison, Gilead’s Chief Scientific Officer and Head of
Research & Development; and Andrew Cheng, Gilead’s Chief Medical Officer
and Executive Vice President, will participate in a fireside chat at the
Jefferies 2018 Healthcare Conference in New York on Wednesday, June 6 at
10:30 a.m. Eastern Time.
The audio portion of the fireside chat will be accessible live through
the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be required to listen to the webcast. The replay will
be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180523006100/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792